REFERENCES
- Plotz PH, Rider LG, Targoff IN, et al. NIH conference. Myositis: immunologic contributions to understanding cause, pathogenesis, and therapy. Ann Intern Med. 1995;122:715–724. doi:10.7326/0003-4819-122-9-199505010-00010.
- Lundberg IE, Tjärnlund A, Bottai M, et al. 2017 European league against Rheumatism/American College of rheumatology classification criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups. Ann Rheum Dis. 2017;76:1955–1964. doi:10.1136/annrheumdis-2017-211468.
- Bottai M, Tjärnlund A, Santoni G, et al. EULAR/ACR classification criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups: a methodology report. RMD Open. 2017;3:e000507. eCollection 2017. doi:10.1136/rmdopen-2017-000507.
- Migliaresi S, Ambrosone L, Tirri G. Eye involvement in dermatomyositis/polymyositis. J Rheumatol. 1996;23:2006–2007.
- Backhouse O, Griffiths B, Henderson T, Emery P. Ophthalmic manifestations of dermatomyositis. Ann Rheum Dis. 1998;57:447–449. doi:10.1136/ard.57.8.447.
- Goldfarb N, Lin SW, Jaimes J, et al. A case of dermatomyositis presenting with eyelid nodules. J Drugs Dermatol. 2013;12:1486–1488.
- Lowry CA, Pilkington CA. Juvenile dermatomyositis: extramuscular manifestations and their management. Curr Opin Rheumatol. 2009;21:575–580. doi:10.1097/BOR.0b013e328331927e.
- Foroozan R. Visual loss from optic neuropathy in dermatomyositis. Rheumatology (Oxford). 2004;43:391–393. doi:10.1093/rheumatology/keh040.
- Bohan A, Peter JB. Polymyositis and dermatomyositis (first of two parts). N Engl J Med. 1975;292:344–347. doi:10.1056/NEJM197502132920706.
- Meyer A, Meyer N, Schaeffer M, Gottenberg JE, Geny B, Sibilia J. Incidence and prevalence of inflammatory myopathies: a systematic review. Rheumatology (Oxford). 2015;54:50–63. doi:10.1093/rheumatology/keu289.
- Love LA, Leff RL, Fraser DD, et al. A new approach to the classification of idiopathic inflammatory myopathy: myositis-specific autoantibodies define useful homogeneous patient groups. Medicine (Baltimore). 1991;70:360–374.
- Garlepp MJ. Genetics of the idiopathic inflammatory myopathies. Curr Opin Rheumatol. 1996;8:514–520.
- Santoro FA, Huang J. Ocular involvement in cutaneous connective tissue disease. Clin Dermatol. 2016;34:138–145. doi:10.1016/j.clindermatol.2015.11.011.
- Cohen BH, Sedwick LA, Burde RM. Retinopathy of dermatomyositis. J. Clin. Neuroophthalmol.. 1985;5:177–179.
- Swierkowska J, Gajecka M. Genetic factors influencing the reduction of central corneal thickness in disorders affecting the eye. Ophthalmic Genet. 2017;38:501–510. doi:10.1080/13816810.2017.1313993.
- Generali E, Cantarini L, Selmi C. Ocular involvement in systemic autoimmune diseases. Clin Rev Allergy Immunol. 2015;49:263–270. doi:10.1007/s12016-015-8518-3.
- Schallhorn JM, Schallhorn SC, Hettinger KA, et al. Outcomes and complications of excimer laser surgery in patients with collagen vascular and other immune-mediated inflammatory diseases. J Cataract Refract Surg. 2016;42:1742–1752. doi:10.1016/j.jcrs.2016.09.018.
- Wegener A, Laser-Junga H. Photography of the anterior eye segment according to Scheimpflug’s principle: options and limitations - a review. Clin Exp Ophthalmol. 2009;37:144–154. doi:10.1111/j.1442-9071.2009.02018.x.
- Mas-Aixala E, Gispets J, Lupón N, Cardona G. The variability of corneal and anterior segment parameters in keratoconus. Cont Lens Anterior Eye. 2016;39:466–470. doi:10.1016/j.clae.2016.05.003.
- Chen Y, Bao YZ, Pei XT. Morphologic changes in the anterior chamber in patients with cortical or nuclear age-related cataract. J Cataract Refract Surg. 2011;37:77–82. doi:10.1016/j.jcrs.2010.07.029.
- He W, Zhu X, Wolff D, Zhao Z, Sun X, Lu Y. Evaluation of anterior chamber volume in cataract patients with swept-source optical coherence tomography. J Ophthalmol. 2016;2016:8656301. doi:10.1155/2016/8656301.
- Smith SM, Birk DE. Focus on molecules: collagens V and XI. Exp Eye Res. 2012;98:105–106. doi:10.1016/j.exer.2010.08.003.
- Findlay AR, Goyal NA, Mozaffar T. An overview of polymyositis and dermatomyositis. Muscle Nerve. 2015;51:638–656. doi:10.1002/mus.24566.
- Şahin M, Yüksel H, Şahin A, et al. Evaluation of the anterior segment parameters of the patients with scleroderma. Ocul Immunol Inflamm. 2016;30:1–6. doi:10.3109/09273948.2015.1115079.
- Gunes A, Erkol Inal E, Tok L, Tok O. Assessment of corneal parameters with scheimpflug imaging in patients with ankylosing spondylitis. Semin Ophthalmol. 2017;32:276–280. doi:10.3109/08820538.2015.1068340.
- Cingü AK, Cınar Y, Türkcü FM, et al. Evaluation of corneal parameters with scheimpflug imaging in patients with rheumatoid arthritis. Ocul Immunol Inflamm. 2013;21:360–365. doi:10.3109/09273948.2013.797472.
- Gunes A, Inal EE, Tok L, Tok O. Evaluation of central and peripheral corneal thicknesses in patients with rheumatoid arthritis. Arq Bras Oftalmol. 2015;78:236–240. doi:10.5935/0004-2749.20150061.
- Guzey M, Satici A, Karaman SK, et al. The effect of topical cyclosporine A treatment on corneal thickness in patients with trachomatous dry eye. Clin Exp Optom. 2009;92:349–355. doi:10.1111/j.1444-0938.2009.00369.x.
- Karadayi K, Ciftci F, Akin T, Bilge AH. Increase in central corneal thickness in dry and normal eyes with application of artificial tears: a new diagnostic and follow-up criterion for dry eye. Ophthalmic Physiol Opt. 2005;25:485–491. doi:10.1111/j.1475-1313.2005.00336.x.
- Carnahan MC, Goldstein DA. Ocular complications of topical, peri-ocular, and systemic corticosteroids. Curr Opin Ophthalmol. 2000;11:478–483.